Kim H - Search Results

1

Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo.

Kim H, Barton E, Muja N, Yakar S, Pennisi P, Leroith D. Kim H, et al. Endocrinology. 2005 Apr;146(4):1772-9. doi: 10.1210/en.2004-0906. Epub 2004 Dec 23. Endocrinology. 2005. PMID: 15618350

2

Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.

Héron-Milhavet L, Haluzik M, Yakar S, Gavrilova O, Pack S, Jou WC, Ibrahimi A, Kim H, Hunt D, Yau D, Asghar Z, Joseph J, Wheeler MB, Abumrad NA, LeRoith D. Héron-Milhavet L, et al. Among authors: kim h. Endocrinology. 2004 Oct;145(10):4667-76. doi: 10.1210/en.2003-1543. Epub 2004 Jul 1. Endocrinology. 2004. PMID: 15231693

3

The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting.

Yakar S, Kim H, Zhao H, Toyoshima Y, Pennisi P, Gavrilova O, Leroith D. Yakar S, et al. Among authors: kim h. Pediatr Nephrol. 2005 Mar;20(3):251-4. doi: 10.1007/s00467-004-1613-y. Epub 2005 Jan 12. Pediatr Nephrol. 2005. PMID: 15645308 Review.

4

Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.

Kim H, Haluzik M, Gavrilova O, Yakar S, Portas J, Sun H, Pajvani UB, Scherer PE, LeRoith D. Kim H, et al. Diabetologia. 2004 Dec;47(12):2215-25. doi: 10.1007/s00125-004-1581-6. Epub 2004 Dec 15. Diabetologia. 2004. PMID: 15662559

5

Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness.

Le Roith D, Kim H, Fernandez AM, Accili D. Le Roith D, et al. Among authors: kim h. Curr Opin Clin Nutr Metab Care. 2002 Jul;5(4):371-5. doi: 10.1097/00075197-200207000-00004. Curr Opin Clin Nutr Metab Care. 2002. PMID: 12107371 Review.

6

Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.

Kim H, Haluzik M, Asghar Z, Yau D, Joseph JW, Fernandez AM, Reitman ML, Yakar S, Stannard B, Heron-Milhavet L, Wheeler MB, LeRoith D. Kim H, et al. Diabetes. 2003 Jul;52(7):1770-8. doi: 10.2337/diabetes.52.7.1770. Diabetes. 2003. PMID: 12829645

7

Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes.

Zhao H, Yakar S, Gavrilova O, Sun H, Zhang Y, Kim H, Setser J, Jou W, LeRoith D. Zhao H, et al. Among authors: kim h. Diabetes. 2004 Nov;53(11):2901-9. doi: 10.2337/diabetes.53.11.2901. Diabetes. 2004. PMID: 15504971

8

Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice.

Kim H, Pennisi PA, Gavrilova O, Pack S, Jou W, Setser-Portas J, East-Palmer J, Tang Y, Manganiello VC, Leroith D. Kim H, et al. Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1227-36. doi: 10.1152/ajpendo.00344.2005. Am J Physiol Endocrinol Metab. 2006. PMID: 16682489 Free article.

9

Identification of a conserved and functional iron-responsive element in the 5'-untranslated region of mammalian mitochondrial aconitase.

Kim HY, LaVaute T, Iwai K, Klausner RD, Rouault TA. Kim HY, et al. J Biol Chem. 1996 Sep 27;271(39):24226-30. doi: 10.1074/jbc.271.39.24226. J Biol Chem. 1996. PMID: 8798666 Free article.

10

Neurosteroid withdrawal model of perimenstrual catamenial epilepsy.

Reddy DS, Kim HY, Rogawski MA. Reddy DS, et al. Among authors: kim hy. Epilepsia. 2001 Mar;42(3):328-36. doi: 10.1046/j.1528-1157.2001.10100.x. Epilepsia. 2001. PMID: 11442149 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101,332 results

Search Page

Filters